Serum inflammatory markers and risk of colorectal cancer in patients with inflammatory bowel diseases (Q33857049)

29 July 2017

title

Serum inflammatory markers and risk of colorectal cancer in patients with inflammatory bowel diseases (English)

1 reference

inflammatory bowel diseases

29 July 2017

main subject

0 references

1 reference

1 reference

Peter Szolovits

6

0 references

Isaac Kohane

series ordinal

11

object named as

Isaac Kohane

1 reference

29 July 2017

3

Tianxi Cai

1 reference

29 July 2017

9

Elizabeth W Karlson

1 reference

29 July 2017

10

Shawn N Murphy

1 reference

29 July 2017

Ashwin N Ananthakrishnan

series ordinal

1

object named as

Ashwin N Ananthakrishnan

1 reference

29 July 2017

5

Vivian S Gainer

1 reference

29 July 2017

7

Stanley Y Shaw

1 reference

29 July 2017

8

Susanne Churchill

1 reference

29 July 2017

12

Katherine P Liao

1 reference

29 July 2017

Su-Chun Cheng

2

1 reference

29 July 2017

Andrew Cagan

series ordinal

4

1 reference

29 July 2017

language of work or name

English

0 references

publication date

7 January 2014

1 reference

Clinical Gastroenterology and Hepatology

29 July 2017

published in

1 reference

29 July 2017

volume

12

1 reference

29 July 2017

issue

8

1 reference

29 July 2017

page(s)

1342-8.e1

1 reference

Inflammation is an independent risk factor for colonic neoplasia in patients with ulcerative colitis: a case-control study.

29 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4085150

Inflammation and disease duration have a cumulative effect on the risk of dysplasia and carcinoma in IBD: a case-control observational study based on registry data

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4085150

Normalization of plasma 25-hydroxy vitamin D is associated with reduced risk of surgery in Crohn's disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4085150

TLR4 activates the β-catenin pathway to cause intestinal neoplasia

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4085150

Colorectal cancer in inflammatory bowel disease: results of the 3rd ECCO pathogenesis scientific workshop (I).

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4085150

Improving case definition of Crohn's disease and ulcerative colitis in electronic medical records using natural language processing: a novel informatics approach

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4085150

The future of inflammatory bowel disease therapy: where do we go from here?

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4085150

Inflammation and colorectal cancer: colitis-associated neoplasia

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4085150

The dual role of inflammation in colon carcinogenesis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4085150

Colorectal cancer in patients with inflammatory bowel disease: can we predict risk?

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4085150

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4085150

Mucosal healing in inflammatory bowel diseases: a systematic review

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4085150

Decreasing risk of colorectal cancer in patients with inflammatory bowel disease over 30 years

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4085150

The utility of biomarkers in the diagnosis and therapy of inflammatory bowel disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4085150

Validity of administrative data for the diagnosis of primary sclerosing cholangitis: a population-based study.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4085150

Inflammatory markers are associated with risk of colorectal cancer and chemopreventive response to anti-inflammatory drugs

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4085150

Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002).

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4085150

Diagnosis and management of dysplasia in patients with ulcerative colitis and Crohn's disease of the colon

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4085150

C-reactive protein and colorectal cancer risk: a systematic review of prospective studies

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4085150

Blocking TNF-alpha in mice reduces colorectal carcinogenesis associated with chronic colitis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4085150

Colitis and cancer: a tale of inflammatory cells and their cytokines

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4085150

Role of Toll-like receptors in gastrointestinal malignancies

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4085150

Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4085150

Epidemiology and risk factors for colorectal dysplasia and cancer in ulcerative colitis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4085150

Laboratory markers in IBD: useful, magic, or unnecessary toys?

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4085150

The role of C-reactive protein as an inflammatory marker in gastrointestinal diseases

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4085150

Correlation of C-reactive protein with clinical, endoscopic, histologic, and radiographic activity in inflammatory bowel disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4085150

C-reactive protein as a marker for inflammatory bowel disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4085150

Review article: colorectal carcinoma and inflammatory bowel disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4085150

C-reactive protein and the risk of incident colorectal cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4085150

The risk of colorectal cancer in ulcerative colitis: a meta-analysis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4085150

Can mucosal healing be a cost-effective endpoint for biologic therapy in Crohn's disease? A decision analysis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4085150

Circulating C-reactive protein concentrations and risks of colon and rectal cancer: a nested case-control study within the European Prospective Investigation into Cancer and Nutrition

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4085150

C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4085150

Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4085150

Body mass index and colon cancer in a national sample of adult US men and women

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4085150

Validity of cancer diagnosis in a primary care database compared with linked cancer registrations in England. Population-based cohort study

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4085150

Blockade of interleukin 6 trans signaling suppresses T-cell resistanceagainst apoptosis in chronic intestinal inflammation: Evidence in Crohn diseaseand experimental colitis in vivo

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4085150

The clinical significance of serum C reactive protein levels in Crohn's disease. Results of a prospective longitudinal study

29 October 2018

1 reference

12 December 2020

AGA medical position statement on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease

1 reference

12 December 2020

1 reference

12 December 2020

Predictors of infliximab failure after azathioprine withdrawal in Crohn's disease treated with combination therapy

1 reference

12 December 2020

1 reference

12 December 2020

10.1016/J.CGH.2013.12.030

Identifiers

DOI

1 reference

29 July 2017

1 reference

29 July 2017

1 reference